Trace Neuroscience · 1 month ago
VP, Finance and Corporate Controller
Trace Neuroscience is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases, particularly ALS. The VP, Finance and Corporate Controller will be responsible for overseeing all financial and accounting operations, providing guidance to the leadership team, and ensuring compliance with regulatory requirements.
Biotechnology
Responsibilities
Manage all day-to-day accounting operations including general ledger, accounts payable, cash flow analysis and more
Partner with HR to process payroll and associated compliance, ensuring accuracy and timeliness
Implement, maintain and optimize financial software and systems, ensuring efficiency data integrity and automation across finance operations
Prepare monthly, quarterly, annual financial statements in accordance with US GAAP
Manage cash management strategies; including banking relationships, investments, disbursements to optimize cash flow, cash collection processes and monitoring cash position
Ensure compliance with Biotech specific regulatory and financial reporting requirements
Implement internal controls
Provide actionable financial insights and reports to cross-functional teams, supporting operational decision-making
Provide updates to the Executive Leadership team, providing visibility into financial health, cash position and operational performance
Lead the end-to-end annual budgeting and forecasting process, working with various Budget Owners, tracking and sharing variance reports with stakeholders throughout the year
Monitor and communicate budget variances to stakeholders, providing recommendations for corrective action
Manage the annual audit process and tax filings, acting as the primary liaison with external auditors
Develop and maintain comprehensive accounting and financial policies and procedures to support scalability and audit readiness
Build long-term financial projections and scenario analyses to guide capital planning, fundraising strategy and operational decisions
Contribute to organizational strategic planning, iterating with the Leadership Team to update objectives, goals, and initiatives
Provide financial analysis for new initiatives, partnerships, and programs
Advise on financial implications of operational and organizational decisions
Support additional duties as assigned to drive company growth and mission alignment
Qualification
Required
Bachelor's degree in Finance and/or Accounting required
CPA required
Minimum of 10 years of progressive finance and accounting experience with increasing leadership responsibilities
Minimum 5 years experience in biotechnology or pharmaceutical-related industry, with a preference for experience in a lean or early-stage biotech environment
Experience with managing and evaluating full-cycle budgeting, forecasting process, and financial modeling, providing actionable insights to support strategic decision-making
Experience partnering with a Venture Capital or Private Equity-backed company, including investor reporting and capital management
Advanced Excel, financial modeling and analytical capabilities to support scenario planning, cash flow management and strategic initiatives
Excellent organizational, project management, and leadership skills capable of analyzing and scaling finance operations in a dynamic, early-stage biotech
Strategic, independent thinker with a strong scientific and business acumen
Excellent communication skills, capable of presenting financial insights to boards, investors and cross-functional stakeholders
Ability to thrive in a small, fast-paced biotech or startup environment, able to translate complex data into actionable recommendations
Motivated to lead through ambiguity and adapt to rapidly evolving and shifting priorities
Collaborative, solutions-focused, and adept at building trusted partnerships across executive, operational, and scientific teams
Preferred
MBA or advanced degree is preferred
Successful experience in a Big 4 or Tier 2 accounting firm is preferred
Company
Trace Neuroscience
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases.
Funding
Current Stage
Early StageCompany data provided by crunchbase